Of the ten coronavirus vaccine-producing laboratories in the world, Argentina is in negotiations with five of them: AstraZeneca, Pfizer, Sinopharm, Janssen and the Gamaleya Research Institute, which develops Sputnik V. Three of them are currently conducting clinical studies in the country, as reported by the News Agency Télam.All of these vaccines are in phase 3, that is, the last stage of clinical studies. According to Télam, Argentina would get millions of doses from December that can be applied as soon as they are approved by the National Administration of Medicines, Food and Medical Technology (ANMAT) and other regulatory entities. These doses would be in addition to the more than 9 million to be achieved through Covax, a collective purchasing mechanism promoted by the World Health Organization (WHO) to come at the end of February. In line with that, the Government enacted last Friday the Law on Vaccines aimed at Generating Immunity against Covid-19 (Law No. 27,573) which, as explained by the Minister of Health of the Nation, is a necessary tool to advance contracts with the different vaccine developers and also a requirement of Covax.
On this subject, the Minister of Health, Ginés González García, stated in a radio interview today that all vaccines applied in Argentina will have passed “all the tests of efficiency and safety” and added that “its application will not be mandatory.” We are going to ensure that the vaccines we apply to Argentines have passed all the efficiency and safety tests, in that we must be calm,” he explained today in dialogue with Radio Mitre.
In this note:
